§ 01 / 02
Profile
Biography and focus

Managing Partner · LeverVenture
Former Chairman of JumpStart Inc. He has founded, scaled and exited companies across media, nutrition, real estate and human-resources technology, and owned the revenue line in every one of them. What he brings to a position is that operating experience at scale, investment acumen, an advanced diligence capability, and technology and artificial-intelligence expertise. He invests the way he operated: inside the business, on the plan, alongside the management team.
- Focus
- Value creation, technology and artificial intelligence, operating and finance discipline
- Diligence
- Advanced diligence capability, applied to every position we underwrite
- Coverage
- The United States, from Cleveland and Miami
§ 02 / 02
Insights
Published by José Vasquéz
30 insights on leverventure.com, most recent first.
- Growth Equity in Life Sciences: 2026 Market StudyGrowth Equity
- The Operating Record: What It Supports and What It Does NotGrowth Equity
- Family Office Guide to Emerging Growth Equity ManagersGrowth Equity
- The State of Venture Capital: How the Power Law Broke the Middle — and What Comes NextGrowth Equity
- Operator-Led vs. Financial-Sponsor Growth Equity: What an Operating Partner Changes for LPsGrowth Equity
- Digital Transformation as an Investment Thesis: Why Most Programs Fail and How Operator-Led Capital Fixes ThemArtificial Intelligence
- The J-Curve Is Different in Life Sciences, and Allocators Should Price ItGrowth Equity
- AI Infrastructure for Life Sciences and Healthcare Founders: Where to Build, Where to WaitLife Sciences and Healthcare
- Emerging Growth Equity Managers: The Founder's Complete Evaluation Guide for 2026Growth Equity
- The Operating Partner's First Hundred Days, With Owners and DatesGrowth Equity
- Quality of Earnings in a Company With No EarningsLife Sciences and Healthcare
- SPV, Fund or Co-Invest: Choosing the VehicleGrowth Equity
- Why Life Sciences, Why Now: The Thesis in FullLife Sciences and Healthcare
- Which AI Healthcare Claims Survive a Regulatory RecordArtificial Intelligence
- VC Market Reset: Implications for Growth Equity InvestorsGrowth Equity
- Precedent Transactions When There Are Four ComparablesLife Sciences and Healthcare
- SaaS Business Models: Evolution Beyond the Rule of 40Growth Equity
- Quantum Computing Investment Thesis: Beyond the Hype to 2028 RealityArtificial Intelligence
- Co-Investment, From the Side That Offers ItGrowth Equity
- Platform Company Build-and-Buy Strategy: Scaling Through M&AGrowth Equity
- Operating Partner Evolution: Beyond Advisory to Value CreationGrowth Equity
- Mental Health Tech: The $5.5B Market OpportunityLife Sciences and Healthcare
- Generative AI: Separating Hype from Enterprise ValueArtificial Intelligence
- The Management Fee, and What It Actually Pays ForGrowth Equity
- ESG Integration in Investment Due DiligenceImpact
- Digital Health: From Telemedicine to AI DiagnosticsLife Sciences and Healthcare
- Carve-Out Acquisitions: The Execution PlaybookGrowth Equity
- Building Value Beyond Capital: Our Force Multiplier ApproachGrowth Equity
- AI Implementation Framework for Growth CompaniesArtificial Intelligence
- Growth Equity Firms in AI Healthcare: The Operator's Playbook for Raising Growth Capital in 2025Growth Equity

